Glanzmann study for adults with the condition
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at people with Glanzmann thrombasthenia, a rare bleeding disorder. It aims to gather information about the condition and how it affects people, which may help improve care and treatment in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older
- You have been diagnosed with Glanzmann thrombasthenia (through blood tests or genetic testing)
- You are able to give written consent to join the study
- Your condition is not caused by an autoimmune disorder or medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genes and blood function in people with inherited (passed-down) problems with platelets, white blood cells, or blood clotting. It may help improve understanding of the cause of these conditions and how they work in the body.
This trial is testing a medication called eptacog beta (a clotting factor) to see if it helps control or prevent severe bleeding episodes in people with Glanzmann's thrombasthenia, a rare inherited bleeding disorder.
This study uses special video imaging to try to predict when bleeding may happen in certain inherited bleeding disorders. It may help doctors better anticipate bleeding and guide safer care.
This study is a registry (a large database) that collects information from people who have or may have a blood disorder. It helps researchers learn more about these conditions and improve care.
This study looks at the symptoms, severity, and outcomes of bleeding in children with Glanzmann thrombasthenia who are admitted to the hospital for active bleeding. It aims to understand the clinical pattern to improve care and treatment.
This Swiss study looks at people with unexplained bleeding by using a standardized bleeding score and taking a blood sample. It may help researchers better understand possible bleeding causes even when the reason isn’t clear yet.
Hear when a new Glanzmann Thrombasthenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.